| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | 2,250,000 | 486,675,000 | 21.40% | Put | |
| 2 | TEVA PHARMACEUTICAL INDS LTD | 4,000,000 | 184,040,000 | 8.09% | ||
| 3 | MYLAN N V | 3,873,000 | 147,639,000 | 6.49% | ||
| 4 | PERRIGO CO PLC | 1,213,600 | 112,052,000 | 4.93% | ||
| 5 | GILEAD SCIENCES INC | 1,200,000 | 94,944,000 | 4.17% | ||
| 6 | TEVA PHARMACEUTICAL INDS LTD | 2,000,000 | 92,020,000 | 4.05% | Call | |
| 7 | ENDO INTL | 4,240,000 | 85,436,000 | 3.76% | ||
| 8 | SELECT MED HLDGS CORP COM | 6,025,000 | 81,338,000 | 3.58% | ||
| 9 | GILEAD SCIENCES INC | 1,000,000 | 79,120,000 | 3.48% | Call | |
| 10 | MEDICINES CO | 2,000,000 | 75,480,000 | 3.32% | ||
| 11 | CARDIOVASCULAR SYS INC DEL COM | 3,000,000 | 71,220,000 | 3.13% | ||
| 12 | GENOMIC HEALTH INC COM | 2,458,100 | 71,088,000 | 3.13% | ||
| 13 | BROOKDALE SR LIVING INC | 4,000,000 | 69,800,000 | 3.07% | ||
| 14 | ORTHOFIX INTERNATIONAL NV | 1,500,000 | 64,155,000 | 2.82% | ||
| 15 | LIVANOVA PLC | 1,000,000 | 60,110,000 | 2.64% | ||
| 16 | COMMUNITY HEALTH SYS INC NEW COM | 5,000,000 | 57,700,000 | 2.54% | ||
| 17 | TENET HEALTHCARE CORP THC | 2,500,000 | 56,650,000 | 2.49% | ||
| 18 | NEKTAR THERAPEUTICS COM | 3,200,000 | 54,976,000 | 2.42% | ||
| 19 | UNIVERSAL AMERN CORP NEW | 5,875,000 | 44,944,000 | 1.98% | ||
| 20 | ALKERMES PLC SHS | 937,300 | 44,081,000 | 1.94% | ||
| 21 | VALEANT PHARMACEUTICALS INTL | 1,271,500 | 31,215,000 | 1.37% | ||
| 22 | CONMED CORP | 750,000 | 30,045,000 | 1.32% | ||
| 23 | BIOSCRIP INC | 10,180,000 | 29,420,000 | 1.29% | ||
| 24 | PTC THERAPEUTICS INC | 2,000,000 | 28,020,000 | 1.23% | ||
| 25 | INVITAE CORP | 2,442,122 | 21,393,000 | 0.94% | ||
| 26 | ARENA PHARMACEUTICALS INC | 10,500,000 | 18,375,000 | 0.81% | ||
| 27 | SYNERON MEDICAL LTD ORD SHS | 2,347,593 | 16,809,000 | 0.74% | ||
| 28 | AMAG PHARMACEUTICALS INC COM | 611,390 | 14,985,000 | 0.66% | ||
| 29 | ENDOLOGIX INC | 1,000,000 | 12,800,000 | 0.56% | ||
| 30 | BIOLASE INC | 5,332,394 | 9,332,000 | 0.41% | ||
| 31 | PROTALIX BIOTHERAPEUTICS INC | 13,275,000 | 7,434,000 | 0.33% | ||
| 32 | INNOCOLL AG | 1,059,139 | 6,228,000 | 0.27% | ||
| 33 | Catabasis Pharmaceuticals Inc | 1,000,000 | 6,160,000 | 0.27% | ||
| 34 | PROTALIX BIOTHERAPEUTICS INC | 9,000,000 | 5,642,000 | 0.25% | PRN | |
| 35 | TARGACEPT INC | 1,684,799 | 1,685,000 | 0.07% | PRN | |
| 36 | DEXTERA SURGICAL | 837,483 | 1,583,000 | 0.07% | ||
| 37 | BIOLASE INC | 1,841,173 | 5,000 | 0.00% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001654954-16-003886, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
